they say this is legal in 34 states already .. e.g. user can enter a competition who can shoot better .. each user pays $5 to enter ... so, let's say a million partcipate and the winner collects $5M minus 30% commission to go to GLUU ...
add this plus new advertising reveneu to list of already expanding revenue ... i don't see how this stock will stay below $10 over next 6 months
It works .. Well here is one paper, and results of similar type of technology are pronounced
From this paper, nerve stimulation seems to work well. Sensus makes it easy to use.
People are calling this pump and dump. Maybe not.
It could be that the results of trials that has been going on with DME are coming in as positive and bigger orders are being placed with NURO. Almost always some people tend to find this info before others and they buy (could be DMEs, tutes that have check points with DMEs, etc) ..maybe, they bought in Wed and Thursday. Some small traders bought and sold lots of shares as euphoria sites in during the last two days.
I bought in today and am looking forward to see what CEO has to say next week. I said it before, and say it again. If Sensus helps patients, longs have hit a jackpot. You have most of ingredients for a big run up
Low enterprise value, good product, FDA approval acts as a barrier to entry, appears to be the only player in market for now, management that has been around the block for a good while and have al lot to gain if stock goes up.
Maybe $3 is just a tase of things to come in 2014 and 2015.
Ceres leads technology of sweet sorghum and high biomass sorghum to the 6th National Congress of Bioenergy
Event happens in Araçatuba and is considered one of the most important national calendar chain sugarcane
Ceres distributes in Brazil hybrids Blade ® brand and prepares the third harvest commercial sorghum crop in the sugarcane industry
Piracicaba (SP) - October 30, 2013 - Ceres Seeds Brazil focuses its hybrids of sweet sorghum and high biomass sorghum event in 6th National Congress of Bioenergy, on 6 and 7 November in the city of São Paulo Araçatuba. Considered one of the most important events in the Brazilian sugarcane industry, the meeting is sponsored by udop - Union of Bioenergy Producers - and bring together around 150 speakers and 1000 attendees. Ceres is among the supporters of the event, in addition to two speakers in programming.
Subsidiary of US-based Ceres, Inc., Ceres Seeds Brazil heads for the third season trade involving their hybrids Blade ® Sweet sorghum culture in the country that allows plants to produce ethanol in the offseason of cane sugar was adopted for more than 30 companies in the period 2012/13, including the largest sugar and ethanol groups.
Under his direction, the focus Ceres two core strategies for the next production cycle of its line of hybrid sorghum, which begins in November and ends in April next year to come. Will launch the first commercial hybrid sorghum high biomass recorded in Brazil, Blade ® brand of CB 7520 and will provide technical support in the management of its portfolio of hybrids to a group of selected clients.
According to the engineer and master in Plant Science Marcelo Gullo, manager of marketing and business development at Ceres Brazil, the high biomass sorghum hybrid that combines attributes make it highly recommended as a complement to sugarcane bagasse in the cogeneration of electricity and the production of cellulosic ethanol (second generation ethanol), and ensure the cost of raw materials during the offseason cane. This hybrid, says the executive, presents up to 23% fiber in its composition and productivity records of up to 70 tonnes per hectare.
It has taken this company 10 years to put all building blocks together .. Examplem they spend through 2011 to get lab inspected and approved by FDA
With this FDA approval, they have validation and so will sign up new partners more quickly and with better terms
This approved drug will put money into cash flow positive for the next 10 years !!!! Do you guys get this .. No more losses for the next 10 years .. Exclusivity will have some more revenue during first 6 months, but aside form that, on the low side, they will be breakeven or profitable for next 10 years ...
from what I read, they have addressed some of the major technical issues like yield in manufacturing (switching to PET film has increased yield) and brightness (still not so good, but at 6 micron is pretty good).
The only point that seems very important comes from Geoff Walker, a senior touch technologist at intel, he says that significant problem with metal mesh adoption is in supply chain. More specifically,
Film based module makers ("back-end" suppliers) such as O-Film and Young Fast are all making their own metal mesh and don't want to use other supplier's mesh. If they are forced to do so by an OEM, they increase the price to make up the missing margin. He says this makes it very difficult for atml, unxl,Fuji to makrket their product.
I really don't understand what above means and implication and if some of the longs could share their thoughts on this
Don't copy and paste other people,s ideas .. Have some original thoughts .. You are a pumper and bad omen for any stock
I do agree that zynga should buy Gluu ASAP .. They have cash and Gluu has got games and platform .. I don't think Gluu want to sell cheap though
EW3 is most popular in china, Japan ... If each release was going to be as successful as DH, then this would be a $3B company now .. I think investment thesis here is that they can better monetize the older games and will get a rev up in advertising
this stock is going up .. it has a beautiful chart, basing, moving averages, etc
maybe their stuff really works, maybe not, maybe they will be leader, maybe not, but stock chart is telling me it going up.
I will day trade this stock and will let you know. I will add on pull backs and sell on fast run ups. But net long unit it 200 dma reverses trend.
GL to all.
i always laugh when I see so much hope and optimism. I will be trading this sock on the long side. That means buy on pull backs, sell on fast run ups and if price goes down i will hold my position.
I have been around for a long time and this stock certainly looks like a long term winner. but, maybe $20 tops .. Unless they cure cancer .. in that case, i would say $2,000 .. but i mean CURE ... nit like these idiot drugs, giving patients 5 more months to live
if they cure cancer, then yes, 1 trillion is too low .. frankly, i would love them as I probably die from cancer since most in my dad;s family died of stomach or colon cancer .. so, dam it, if anyone can cure or immunize against cancer, i say all power to them .. better do it soon as i will probably get hit with it in 20 years !!!
for now stock is going up, it may try to back fill $1.90, but does not look like it to me
float is about 9M or less .. how can this get traded like this is a mystery .. volume is like a 100M share float
In April 2013, we entered into an agreement with an Eco-System Partner (the “Agreement”), whereby we will receive $10 million of cash proceeds to assist us in increasing our production capacity. The Agreement requires us to have the capability to produce at least 1 million sensor units per month (as defined in the Agreement) by April 2014. Upon achieving the minimum production capability and meeting the required quality standards specified in the Agreement, we will record non-recurring engineering revenue for the total amount of cash proceeds received. As of June 30, 2013, we have received $5 million, which is recorded as deferred revenue in the accompanying balance sheet.
Upon achieving the deliverables of the Agreement, we will pay a commission to the Eco-System Partner of 10%, on revenue derived from the sales of UniBoss sensors directly to the Eco-System Partner or to those of the Eco-System Partner’s manufacturing partners that use the Eco-System Partner’s Preferred Price and Capacity License Agreement. The commission amount is capped at $18.5 million.
So, the touch is counting on at least $100 million revenue
1- He almost, but guaranteed that they will get waiver and PO shortly after wards .. Probably in October
2- he said Eco partner is intel
3- he sounded like he knew all the ins and outs of biz and not just a high level CEO
4- sounds like their method works !
Now, can someone explain with 12M share outstanding and float after all these exchanges about 6M and 5M shorts , how can you have such high volume day after day
I love DH ... They have a feature that you need to pay or wait 10 minutes to play. given that 99% wait and 1% pays, I think they make more money if they give three option
1- watch a video ad (say about a hunting store supplies)
2- wait 10 minutes
3- pay for no ad and no wait time
Ozark .. Thank you very much for your insight .. Two questions / comments
1- 7.5% market share is for a competitive landscape with many players .. In such.caes, 25% gross profit is more reasonable (versus 75%) .. Don't they have a unique product that has no serious completion and that is why they can command a 75% gross margin .. If yes, then market share should be closer to 60% ..So I see either 75% margin and 60% market share if they have a great product or 10%,market share and 30% gross margin if it is another me too product .. Your scenario is neither .. I like to get your thoughts on this
2- of the markets you listed, which ones they can go after now and which ones are future if they get additional approvals from FDA ?
hold and do not sell. 1/3 of diabetics have some sort of pain in their foot. Narcotics are good for some. But others prefer non-narcotics pain relief. This is the only simple device to get pain relief. Once patient feedback moves away from CEO slide to internet, $10 will be too cheap
cash flow breakeven or greater is huge ...
FDA Validation is even bigger
2014 and beyond is harvest time of over 15 years of hard work by this company
a partner with upfront payment, milestone and royalties could change this pretty quickly .. $500M a year is just too big